Chemotherapy for Intramedullary Tumors in Children
Author Information
Author(s): Doireau V, Grill J, Zerah M, Lellouch-Tubiana A, Couanet D, Chastagner P, Marchal J C, Grignon Y, Chouffai Z, Kalifa C
Primary Institution: Gustave Roussy Institute
Hypothesis
The role of chemotherapy in treating unresectable and recurrent intramedullary gliomas in children is unclear.
Conclusion
The chemotherapy regimen showed promising results, with most children responding positively and remaining alive after treatment.
Supporting Evidence
- Seven of the eight children responded clinically and radiologically.
- Four children were in radiological complete remission at the end of the treatment.
- After a median follow-up of 3 years, all but one child are alive.
Takeaway
Doctors tried a special medicine to help kids with a type of brain tumor, and most of the kids got better and are still alive.
Methodology
Eight children were treated with a 16-month chemotherapy regimen involving multiple drugs.
Limitations
The study had a small sample size and was conducted over a limited time frame.
Participant Demographics
Children with unresectable or recurrent intramedullary glioma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website